Annual Scientific Meeting

High-Risk Crohn's Disease – More Options, More Questions?

Speaker(s)

• 

  Uma Mahadevan, MD, FACG

  Professor of Clinical Medicine, University of California, San Francisco; Co-Medical Director
  UCSF Center for Colitis and Crohn's Disease
  San Francisco, CA

  Consultant: AbbVie, Bristol-Myers Squibb, Celgene, Gilead, Janssen, Lilly, Takeda
  Grant/Research Support: Genentech, Pfizer
  

Learning Objectives:

• Position the newer mechanisms of action into the treatment algorithm for high-risk Crohn's disease patients.